Preclinical in vivo studies is a critical step in drug development. In vivo imaging in such studies can benefit drug development with rapid and predictive assays to assess drug toxicity and efficacy to reduce clinical attrition rates. High frequency ultrasound imaging will be addressed in this regard by the panel of speakers.
